DD

Daljit Dua

Active Director Director DIN 02054744
DIN 02054744 First appointment Dec 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2004
Shareholding value •••• Premium profile

About Daljit Dua

Data last updated:

Daljit Dua is a Director at Tymon Healthcare Private Limited (since 2004). The company operates in Healthcare. Tymon Healthcare Private Limited reported revenue of ₹2.25 Cr (FY 2025).

DIN 02054744
Primary Designation Director
Industry Healthcare
First Appointment 15 Dec 2004
Oldest Company Age 23 yrs
Largest company Tymon Healthcare Private Limited · ₹2.25 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tymon Healthcare Private Limited U24232PB2003PTC026038
Director15 Dec 20042003₹2.25 Cr (FY 2025)Active

Board colleagues of Daljit Dua

NameDINCompanyDesignation
Hitesh Dua02054536Tymon Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tymon Healthcare Private Limited
Premium access

Shareholding and investment profile for Daljit Dua

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daljit Dua

Daljit Dua currently holds 1 directorship: Tymon Healthcare Private Limited (Director, since 15 Dec 2004, revenue ₹2.25 Cr (FY 2025)).

Daljit Dua was first appointed on 15 Dec 2004 as Director at Tymon Healthcare Private Limited.

The current boards of Daljit Dua's companies include Hitesh Dua (Tymon Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available